- BI 1819479 StudyThis study is to find out whether a medicine called BI 1819479 helps people with Idiopathic Pulmonary Fibrosis (IPF).Trial Category: Featured Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: ACT New Zealand NSW TAS VIC Trial Status: Recruiting Trial Type: Interventional
- REBUILD-SM TrialA Randomised Clinical Trial of a digital Self-Management package for people with Interstitial Lung Disease (REBUILD-SM trial).Trial Category: Featured Trial Age Group: Over 18 years Trial Disease Type: Interstitial Lung Disease (ILD) Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: NSW QLD VIC Trial Status: Recruiting Trial Type: Interventional
- CORALCough Reduction in IPF with nalbuphine ER.Trial Age Group: Over 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW SA VIC WA Trial Status: Recruiting Trial Type: Interventional
- GRIPFGenetic Research in Idiopathic Pulmonary Fibrosis.Trial Age Group: Over 18 years Under 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient and Carer Trial Phase: Not applicable Trial Location: NSW QLD SA VIC Trial Status: Recruiting Trial Type: Observational
- SHIELDThe SHIELD Whole Lung Lavage Observational Cohort Study.Trial Age Group: Over 18 years Trial Disease Type: Silicosis Trial Participant Type: Patient Trial Phase: Not applicable Trial Location: NSW QLD VIC Trial Status: Recruiting Trial Type: Observational
- SNDX-6352-0506A 26-Week, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Efficacy, Safety, and Tolerability of Axatilimab in Subjects with Idiopathic Pulmonary Fibrosis (IPF).Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: QLD Trial Status: Recruiting Trial Type: Interventional
- BEACON-IPFA Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF).Trial Age Group: Over 40 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: New Zealand NSW QLD SA VIC WA Trial Status: Recruiting Trial Type: Interventional
- The TELO-SCOPE StudyAttenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis.Trial Age Group: Over 18 years Under 18 years Trial Disease Type: Idiopathic Pulmonary Fibrosis (IPF) Interstitial Lung Disease (ILD) Progressive Fibrosing Interstitial Lung Diseases (PF-ILD) Pulmonary Fibrosis (PF) Trial Participant Type: Patient Trial Phase: Phase 2 Trial Location: NSW QLD VIC WA Trial Status: Recruiting Trial Type: Interventional